miRNAs as Biomarkers for Disease Detection

This is a block seminar covering topics related to miRNAs and their use as disease biomarkers.



Registration from April 19th, 2017 to April 26th, 2017 HERE
Kick-off meeting [optional] June 26th, 2017 at 16:00 c.t. in E2.1, room 206
Deadline to register in HISPOS OR de-register from seminar July 17th, 2017 (3 weeks after the kick-off meeting) (3 weeks after the kick-off meeting)
Deadline for feedback * [optional] July 30th, 2017 (4 weeks before the presentations)
Presentations August 28th, 2017 at 09:00 c.t. in E2.1, room 206 (in the lecture-free period)
Summary submission deadline September 4th, 2017 (1 week after the presentations)
  • *If you would like to get feedback about your slides, e.g. to improve your presentation before the talk, send your slides to the tutor before the feedback deadline. We strongly encourage you to take this opportunity. Before sending in the slides, check out our presentations guidelines. Please note: The more complete the submitted presentation the more helpful the feedback can be. Please try to avoid submitting half-finished slides.
  • presentation guidelines
  • presentation guidelines checklist

Place and Time:

  • Place: Building E2.1, room 206
  • Time: 09:00 c.t (August 28th, 2017)

Certificate requirements:

  • Successful presentation:
    • Talk: 40 minutes (seminar)
    • Questions from the audience after the presentation
  • Attendance to all presentations
  • Submitting a summary (ca. 2 pages)


Nr. Presentation Topic Participant
1 Seminar MicroRNAs accurately identify cancer tissue origin Maximilian G.
2 Seminar Toward the blood-borne miRNome of human diseases Amanuel G.
3 Seminar Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection Ling X.
4 Seminar High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer Shashwat S.
5 Seminar Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma
Nihit A.
6 Seminar Melanoma MicroRNA Signature Predicts Post-Recurrence Survival Nora T.